Enabling Technologies — Net Sales
Stryker Enabling Technologies — Net Sales decreased by 10.3% to $26.00M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful adoption of the company's digital surgery ecosystem and growing market penetration of capital-intensive medical platforms. A decrease may signal longer hospital capital expenditure cycles or increased competitive pressure in the robotic surgery space.
Detailed definition
This metric represents the total revenue generated from the sale of advanced medical technology platforms, including rob...
Peer comparison
Comparable to robotic surgery and digital health segments at major medical device peers, often evaluated based on the installed base growth and the attach rate of recurring service revenue.
syk_segment_enabling_technologies_net_salesHistorical Data
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $29.00M | $26.00M |
| QoQ Change | — | -10.3% |
| YoY Change | — | -10.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's enabling technologies — net sales?
- Stryker (SYK) reported enabling technologies — net sales of $26.00M in Q1 2026.
- What does enabling technologies — net sales mean?
- Total revenue generated from the sale and service of robotic surgery systems, navigation software, and digital operating room technologies.